Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0006) — New York, New York

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0006) is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0006) has participated in 1 clinical trials.

Therapeutic areas: Merkel Cell Carcinoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0006)?

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0006) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0006) conducted?

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0006) has 1 clinical trials on record. Their work covers Merkel Cell Carcinoma.

Is Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0006) accredited by Crixeo Health?

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0006) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0006)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.